Question 1

Am I eligible for this trial based on my previous treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) clinical trial (NCT06842498). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of FG-3246?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) clinical trial (NCT06842498). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) clinical trial (NCT06842498). Contact the study team or your healthcare provider for specific answers.

Question 4

What does the biopsy process involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) clinical trial (NCT06842498). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) clinical trial (NCT06842498). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if my cancer progresses while I'm in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) clinical trial (NCT06842498). Contact the study team or your healthcare provider for specific answers.

What this study is about